Huntington National Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $435 | Sell |
20
-5
| -20% | -$97 | ﹤0.01% | 2451 |
|
|
2025
Q4 | $538 | Buy |
25
+10
| +67% | +$211 | ﹤0.01% | 2351 |
|
|
2025
Q3 | $289 | Sell |
15
-383
| -96% | -$6.83K | ﹤0.01% | 2489 |
|
|
2025
Q2 | $6.81K | Buy |
398
+82
| +26% | +$3.5K | ﹤0.01% | 1906 |
|
|
2025
Q1 | $20.2K | Buy |
316
+18
| +6% | +$1.9K | ﹤0.01% | 1513 |
|
|
2024
Q4 | $36.2K | Buy |
298
+7
| +2% | +$858 | ﹤0.01% | 1341 |
|
|
2024
Q3 | $36.3K | Buy |
291
+175
| +151% | +$24.2K | ﹤0.01% | 1298 |
|
|
2024
Q2 | $18.3K | Sell |
116
-11
| -9% | -$1.41K | ﹤0.01% | 1485 |
|
|
2024
Q1 | $16.4K | Buy |
127
+39
| +44% | +$4.78K | ﹤0.01% | 1531 |
|
|
2023
Q4 | $8.48K | Buy |
88
+74
| +529% | +$7.1K | ﹤0.01% | 1713 |
|
|
2023
Q3 | $1.7K | Sell |
14
-15
| -52% | -$1.7K | ﹤0.01% | 2087 |
|
|
2023
Q2 | $3.32K | Buy |
29
+3
| +12% | +$387 | ﹤0.01% | 1929 |
|
|
2023
Q1 | $3.58K | Buy |
26
+25
| +2,500% | +$3.24K | ﹤0.01% | 1816 |
|
|
2022
Q4 | $130 | Hold |
1
| – | – | ﹤0.01% | 2037 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2526 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2529 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2469 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | +$85 | ﹤0.01% | 2396 |
|
|
2020
Q4 | – | Sell |
-10
| Closed | -$1K | – | 1907 |
|
|
2020
Q3 | $1K | Buy |
+10
| New | +$1.52K | ﹤0.01% | 1490 |
|
|
2020
Q1 | – | Sell |
-34
| Closed | -$4K | – | 1934 |
|
|
2019
Q4 | $4K | Buy |
+34
| New | +$3.43K | ﹤0.01% | 1526 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
